TAKOMA PARK, Md.–(BUSINESS WIRE)–A surgical team at Rush University Medical Center in Chicago, Ill., with coordination by US Medical Innovations, LLC (USMI) successfully used the Canady HeliosTM Cold Plasma Scalpel (CHCPS) for the selective killing of cancerous tissue during a two-stage liver resection for advanced inoperable liver cancer.
After a one-time pre-market Humanitarian Compassionate-Use Exemption from the Food and Drug Administration (FDA), this groundbreaking surgery was performed on January 16, 2017 on a 40-year-old woman with inoperable Stage IV Intra-hepatic cholangiocarcinoma. The patient …
READ MORE ON BUSINESSWIRE.COM